Also called: TP-7
Selank is a synthetic heptapeptide used for anxiolytic and nootropic research.
The benefits people report — backed by research.

Under the skin
For research purposes only. Not medical advice. Talk to a doctor before use.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity
Semax and selank inhibit the enkephalin-degrading enzymes from human serum
Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo
Optimization of the treatment of anxiety disorders with selank
Physiological Effects of Selank and Its Fragments
Selank upregulates hippocampal BDNF and NGF after a single intranasal dose
Randomized 14-day trial showed anxiolytic efficacy comparable to medazepam without sedation, tolerance, or rebound
Effects of Selank on Behavioral Reactions and Activities of Plasma Enkephalin-Degrading Enzymes in Mice with Different Phenotypes of Emotional and Stress Reactions
Anxiolytic effect of an analog of taftsin (Selank)
Selank: specific anxiolytic action and effects on brain monoamines
Anxiolytic activity of Selank
Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents
The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats
Effectiveness of semax in acute period of hemispheric ischemic stroke
Key moments in Selank’s research and regulatory timeline — sourced and dated.
The most-used peptide combinations, dosing at a glance, and what the research says — one page, one email.
No spam. Unsubscribe anytime.